Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Depreciation & Amortization (CF) (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Depreciation & Amortization (CF) data on record, last reported at $68000.0 in Q4 2021.

  • For Q4 2021, Depreciation & Amortization (CF) rose 2366.67% year-over-year to $68000.0; the TTM value through Dec 2021 reached $147000.0, down 79.0%, while the annual FY2025 figure was $2.6 million, 4.0% up from the prior year.
  • Depreciation & Amortization (CF) reached $68000.0 in Q4 2021 per COGT's latest filing, up from $48000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $352000.0 in Q4 2018 and bottomed at -$3000.0 in Q4 2020.
  • Average Depreciation & Amortization (CF) over 4 years is $216312.5, with a median of $304500.0 recorded in 2018.
  • Peak YoY movement for Depreciation & Amortization (CF): crashed 100.96% in 2020, then soared 2366.67% in 2021.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $352000.0 in 2018, then decreased by 10.8% to $314000.0 in 2019, then plummeted by 100.96% to -$3000.0 in 2020, then skyrocketed by 2366.67% to $68000.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $68000.0 in Q4 2021, $48000.0 in Q3 2021, and $14000.0 in Q2 2021.